) Biological and clinical research on the effects of various autocrine, paracrine and neurocrine factors present in biological samples require the ability to accurately and reliably measure these products. Similarly, the assessment of drug action necessitates the measurement of these agents and their metabolites in tissue and fluid extracts to permit definition of kinetics.
These specific aims constitute the rationale for the primary function of the Analytical Laboratory. This facility has been in existence since 1989. It is a suite consisting of a 600 sq. ft. chemistry laboratory, a 200 sq. ft. 4 degree C cold room, 2 equipment rooms, which contain -70 and -30 degree C freezers, spin vac/lyophilizer, and gamma and scintillation counters. The unit is fully capable of coupling antigens, creating polyclonal rabbit antibodies, coupling of the iodinated ligand, characterization of the antibody and the assay. In addition, it has dedicated HPLCs for identification of column immunoreactivity and gas chromatography for drugs. The laboratory has on-line assays for a variety of peptides (enkephalins, NPY, tachykinins, galanin, bombesin, CGRP), amines and metabolites (catecholamines and indolamines), amino acids, purines (adenosine, ATP/ADP/AMP), prostanoids (PGE1/2; LTB4/C4/D4), and cytokines (TNF, IL1). In addition to these hormones, a variety of drugs and their metabolites are also subject to analysis. These include opiates (morphine, meperidine, fentanyl and derivatives, methadone, codeine), local anesthetics (lidocaine, bupivacaine, mexiletine) injectable anesthetic (propofol, midazolam, barbiturates) and ethanol. The facility is fully equipped for data management with a Windows NT workstation and (secured) campus-wide E thernet-enabled results distribution.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA023100-17
Application #
6316513
Study Section
Project Start
2000-05-26
Project End
2001-04-30
Budget Start
Budget End
Support Year
17
Fiscal Year
2000
Total Cost
$106,014
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Jiang, Qingfei; Jamieson, Catriona (2018) BET'ing on Dual JAK/BET Inhibition as a Therapeutic Strategy for Myeloproliferative Neoplasms. Cancer Cell 33:3-5
Ramirez, Oscar; Aristizabal, Paula; Zaidi, Alia et al. (2018) Implementing a Childhood Cancer Outcomes Surveillance System Within a Population-Based Cancer Registry. J Glob Oncol :1-11
Liu, Liang; Yang, Lin; Yan, Wei et al. (2018) Chemotherapy Induces Breast Cancer Stemness in Association with Dysregulated Monocytosis. Clin Cancer Res 24:2370-2382
Lwin, Thinzar M; Murakami, Takashi; Miyake, Kentaro et al. (2018) Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore. Ann Surg Oncol 25:1079-1085
Singh, Siddharth; Loomba, Rohit (2018) Role of two-dimensional shear wave elastography in the assessment of chronic liver diseases. Hepatology 67:13-15
Hartman, Sheri J; Nelson, Sandahl H; Myers, Emily et al. (2018) Randomized controlled trial of increasing physical activity on objectively measured and self-reported cognitive functioning among breast cancer survivors: The memory & motion study. Cancer 124:192-202
Hoffmann, Hanne M; Gong, Ping; Tamrazian, Anika et al. (2018) Transcriptional interaction between cFOS and the homeodomain-binding transcription factor VAX1 on the GnRH promoter controls Gnrh1 expression levels in a GnRH neuron maturation specific manner. Mol Cell Endocrinol 461:143-154
Liu, Xuxiang; Cao, Minghui; Palomares, Melanie et al. (2018) Metastatic breast cancer cells overexpress and secrete miR-218 to regulate type I collagen deposition by osteoblasts. Breast Cancer Res 20:127
Huang, Justin K; Carlin, Daniel E; Yu, Michael Ku et al. (2018) Systematic Evaluation of Molecular Networks for Discovery of Disease Genes. Cell Syst 6:484-495.e5
Kalyanaraman, Hema; Schwaerzer, Gerburg; Ramdani, Ghania et al. (2018) Protein Kinase G Activation Reverses Oxidative Stress and Restores Osteoblast Function and Bone Formation in Male Mice With Type 1 Diabetes. Diabetes 67:607-623

Showing the most recent 10 out of 862 publications